Pro company pages include CSV downloads for statements, ratios, chart data, and transcript indexes.
JPX · JP
Semiconductor wafer, photoresist, photomask blank, and specialty chemical supplier.
Core upstream materials supplier for advanced logic, memory, and AI accelerator wafer production.
Price
$7310.00
Change
-149.00 (-2.00%)
Market cap
$13.57T
52w range
$4280–$7930
Exchange
JPX
Country
JP
Jason's Chips
Subscribe or sign in with your Substack email for charts, exports, estimates, transcripts, filings, earnings, and news.
Daily close for Shin-Etsu Chemical Co., Ltd.
Download statements, ratios, chart data, and transcript indexes.
Revenue, gross profit, R&D, operating income, EBITDA, net income, and EPS.
Cash, receivables, inventory, PP&E, assets, debt, liabilities, and equity.
Operating cash flow, capital expenditures, and free cash flow.
Enterprise value, valuation multiples, returns, yields, and cash conversion.
Margins, liquidity ratios, valuation ratios, leverage, and per-share metrics.
Five years of daily close and volume data powering the company chart.
Available earnings-call transcript dates by fiscal year and quarter.
| Period | Revenue avg | Revenue range | EPS avg | EPS range | EBITDA avg | EBIT avg | Net income avg | SG&A avg | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| 2027-03-31 | $2.82T | $2.68T - $2.98T | $311.93 | $275.60 - $344.13 | $1.17T | $919.56B | $576.68B | $180.12B | 17 rev / 16 EPS |
| 2028-03-31 | $2.99T | $2.81T - $3.21T | $350.20 | $286.22 - $388.07 | $1.24T | $974.22B | $629.92B | $190.82B | 17 rev / 17 EPS |
| 2029-03-31 | $3.15T | $3.14T - $3.17T | $384.79 | $321.96 - $439.30 | $1.30T | $1.03T | $695.12B | $201.10B | 11 rev / 11 EPS |
| 2030-03-31 | $3.33T | $3.14T - $3.54T | $434.40 | $402.44 - $470.71 | $1.38T | $1.08T | $816.17B | $212.34B | 7 rev / 6 EPS |
| 2031-03-31 | $3.50T | $3.30T - $3.72T | $469.20 | $434.68 - $508.42 | $1.45T | $1.14T | $881.55B | $223.15B | 7 rev / 8 EPS |
| Period | Revenue avg | Revenue range | EPS avg | EPS range | EBITDA avg | EBIT avg | Net income avg | SG&A avg | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $685.93B | $664.05B - $725.39B | $67.70 | $63.56 - $72.22 | $283.69B | $223.45B | $125.78B | $43.77B | 6 rev / 1 EPS |
| 2026-09-30 | $733.38B | $688.55B - $766.92B | $82.73 | $77.67 - $88.26 | $303.32B | $238.91B | $153.71B | $46.80B | 6 rev / 1 EPS |
| 2026-12-31 | $728.90B | $694.63B - $766.38B | $81.26 | $76.30 - $86.70 | $301.46B | $237.44B | $150.99B | $46.51B | 5 rev / 1 EPS |
| 2027-03-31 | $700.75B | $667.80B - $736.79B | $77.96 | $73.19 - $83.17 | $289.82B | $228.28B | $144.84B | $44.71B | 3 rev / 1 EPS |
| 2027-06-30 | $750.40B | $715.12B - $788.99B | $90.21 | $84.70 - $96.24 | $310.36B | $244.45B | $167.61B | $47.88B | 3 rev / 1 EPS |
| 2027-09-30 | $787.40B | $750.38B - $827.89B | $92.68 | $87.02 - $98.88 | $325.66B | $256.50B | $172.20B | $50.24B | 3 rev / 1 EPS |
| 2027-12-31 | $772.40B | $736.08B - $812.12B | $97.00 | $91.07 - $103.49 | $319.45B | $251.62B | $180.24B | $49.28B | 3 rev / 1 EPS |
| 2028-03-31 | $704.30B | $671.18B - $740.52B | $89.71 | $84.22 - $95.70 | $291.29B | $229.43B | $166.68B | $44.94B | 2 rev / 1 EPS |
No price target summary on file.
No grade actions on file.
| Date | Strong buy | Buy | Hold | Sell | Strong sell |
|---|---|---|---|---|---|
| 2026-06-01 | 3 | 11 | 3 | 0 | 0 |
| 2026-05-01 | 3 | 11 | 3 | 0 | 0 |
| 2026-04-01 | 3 | 11 | 3 | 0 | 0 |
| 2026-03-01 | 3 | 11 | 4 | 0 | 0 |
| 2026-02-01 | 3 | 10 | 4 | 0 | 0 |
| 2026-01-01 | 3 | 10 | 4 | 0 | 0 |
| 2025-12-01 | 3 | 10 | 4 | 0 | 0 |
| 2025-11-01 | 3 | 10 | 3 | 0 | 0 |
| Period | Revenue | Gross profit | Gross margin | R&D | Operating income | EBITDA | Net income | EPS |
|---|---|---|---|---|---|---|---|---|
| FY 2026 | $2.57T | $880.79B | 34.2% | $77.80B | $635.21B | $954.17B | $474.46B | $252.68 |
| FY 2025 | $2.56T | $984.12B | 38.4% | $4.64B | $742.11B | $1.06T | $534.02B | $269.52 |
| FY 2024 | $2.41T | $911.21B | 37.7% | $66.78B | $701.04B | $1.02T | $520.14B | $259.41 |
| FY 2023 | $2.81T | $1.21T | 43.2% | $67.20B | $998.20B | $1.24T | $708.24B | $347.84 |
| FY 2022 | $2.07T | $868.00B | 41.8% | $62.45B | $676.32B | $865.91B | $500.12B | $240.76 |
| FY 2021 | $1.50T | $543.70B | 36.3% | $51.26B | $392.21B | $547.34B | $293.73B | $141.35 |
| FY 2020 | $1.54T | $555.74B | 36.0% | $48.54B | $406.04B | $558.47B | $314.03B | $151.03 |
| FY 2019 | $1.59T | $554.06B | 34.8% | $56.44B | $403.70B | $554.33B | $309.13B | $145.20 |
| FY 2018 | $1.44T | $478.42B | 33.2% | $51.77B | $336.82B | $453.67B | $266.24B | $124.86 |
| FY 2017 | $1.24T | $369.00B | 29.8% | $49.02B | $238.62B | $331.70B | $175.91B | $82.57 |
| FY 2016 | $1.28T | $349.79B | 27.3% | $53.16B | $208.53B | $308.99B | $148.84B | $69.89 |
| FY 2015 | $1.26T | $315.14B | 25.1% | $47.16B | $185.33B | $282.25B | $128.61B | $60.41 |
| Period | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|
| FY 2026 | $712.65B | $355.95B | $359.03B |
| FY 2025 | $881.93B | $442.84B | $442.46B |
| FY 2024 | $755.18B | $377.48B | $380.77B |
| FY 2023 | $788.01B | $299.37B | $492.50B |
| FY 2022 | $553.53B | $197.56B | $357.75B |
| FY 2021 | $401.18B | $237.37B | $164.98B |
| FY 2020 | $412.38B | $269.43B | $144.02B |
| FY 2019 | $400.69B | $228.10B | $173.92B |
| FY 2018 | $332.78B | $163.72B | $170.47B |
| FY 2017 | $290.87B | $136.27B | $155.97B |
| FY 2016 | $281.64B | $148.04B | $134.42B |
| FY 2015 | $243.46B | $87.37B | $156.75B |
| Period | Cash + ST inv. | Receivables | Inventory | PP&E | Assets | Debt | Net debt | Liabilities | Equity |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | $1.67T | $521.89B | $790.91B | $2.15T | $5.66T | $243.29B | -$1.42T | $1.02T | $4.46T |
| FY 2025 | $1.81T | $504.76B | $769.97B | $2.07T | $5.64T | $33.90B | -$848.83B | $799.01B | $4.66T |
| FY 2024 | $1.72T | $474.76B | $720.64B | $1.75T | $5.15T | $41.19B | -$548.94B | $723.90B | $4.26T |
| FY 2023 | $1.60T | $466.86B | $688.48B | $1.52T | $4.73T | $47.09B | -$1.20T | $704.18B | $3.87T |
| FY 2022 | $1.44T | $467.69B | $453.66B | $1.29T | $4.05T | $38.95B | -$969.97B | $624.20B | $3.33T |
| FY 2021 | $1.15T | $337.87B | $365.03B | $1.17T | $3.38T | $34.45B | -$767.14B | $493.99B | $2.82T |
| FY 2020 | $1.09T | $318.30B | $365.67B | $1.12T | $3.23T | $30.38B | -$714.75B | $507.34B | $2.65T |
| FY 2019 | $1.04T | $331.32B | $329.49B | $987.96B | $3.04T | $14.92B | -$813.43B | $506.16B | $2.47T |
| FY 2018 | $1.05T | $320.68B | $282.08B | $899.73B | $2.91T | -$43.16B | -$823.61B | $490.11B | $2.35T |
| FY 2017 | $939.27B | $287.85B | $267.16B | $846.57B | $2.66T | $14.64B | -$718.67B | $465.55B | $2.13T |
| FY 2016 | $833.53B | $268.90B | $281.01B | $804.97B | $2.51T | $13.47B | -$474.14B | $429.62B | $2.03T |
| FY 2015 | $765.67B | $292.75B | $276.91B | $784.41B | $2.45T | $14.33B | -$409.52B | $439.60B | $1.96T |
| Period | Gross margin | Op margin | Net margin | Current | Quick | ROE | ROIC | EV / sales | EV / EBITDA | FCF yield | R&D / rev. | Cash cycle |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | 34.2% | 24.7% | 18.4% | 5.9x | 4.4x | 10.6% | 8.8% | 4.0x | 10.8x | 3.1% | 3.0% | 206d |
| FY 2025 | 38.4% | 29.0% | 20.9% | 6.0x | 4.5x | 11.5% | 10.2% | 2.9x | 7.1x | 5.3% | 0.2% | 207d |
| FY 2024 | 37.7% | 29.0% | 21.5% | 5.8x | 4.5x | 12.2% | 10.7% | 5.0x | 11.9x | 3.0% | 2.8% | 208d |
| FY 2023 | 43.2% | 35.5% | 25.2% | 5.6x | 4.3x | 18.3% | 17.6% | 2.7x | 6.1x | 5.7% | 2.4% | 176d |
| FY 2022 | 41.8% | 32.6% | 24.1% | 5.1x | 4.2x | 15.0% | 14.2% | 3.3x | 7.9x | 4.6% | 3.0% | 166d |
| FY 2021 | 36.3% | 26.2% | 19.6% | 5.3x | 4.3x | 10.4% | 9.6% | 4.7x | 12.7x | 2.1% | 3.4% | 174d |
| FY 2020 | 36.0% | 26.3% | 20.3% | 4.8x | 3.9x | 11.8% | 10.6% | 2.4x | 6.7x | 3.2% | 3.1% | 160d |
| FY 2019 | 34.8% | 25.3% | 19.4% | 4.5x | 3.6x | 12.5% | 11.5% | 2.0x | 5.9x | 4.3% | 3.5% | 142d |
| FY 2018 | 33.2% | 23.4% | 18.5% | 4.5x | 3.8x | 11.3% | 10.7% | 2.7x | 8.5x | 3.6% | 3.6% | 136d |
| FY 2017 | 29.8% | 19.3% | 14.2% | 4.9x | 4.0x | 8.2% | 7.5% | 2.7x | 10.2x | 3.8% | 4.0% | 145d |
| FY 2016 | 27.3% | 16.3% | 11.6% | 5.2x | 4.2x | 7.3% | 6.4% | 1.6x | 6.5x | 5.4% | 4.2% | 142d |
| FY 2015 | 25.1% | 14.8% | 10.2% | 4.7x | 3.8x | 6.6% | 5.6% | 2.3x | 10.4x | 4.7% | 3.8% | 146d |
| Period | Revenue | Gross profit | R&D | Op income | Net income | EPS | FCF | Capex | Cash + ST inv. | Inventory | Assets | Debt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | +0.5% | -10.5% | +1575.8% | -14.4% | -11.2% | -6.2% | -18.9% | +19.5% | -8.0% | +2.7% | +0.4% | +617.6% |
| FY 2025 | +6.1% | +8.0% | -93.0% | +5.9% | +2.7% | +3.9% | +16.2% | -17.4% | +5.3% | +6.8% | +9.5% | -17.7% |
| FY 2024 | -14.0% | -24.9% | -0.6% | -29.8% | -26.6% | -25.4% | -22.7% | -26.7% | +7.4% | +4.7% | +8.8% | -12.5% |
| FY 2023 | +35.4% | +39.9% | +7.6% | +47.6% | +41.6% | +44.5% | +37.7% | -50.9% | +11.5% | +51.8% | +16.7% | +20.9% |
| FY 2022 | +38.6% | +59.6% | +21.8% | +72.4% | +70.3% | +70.3% | +116.8% | +17.1% | +24.6% | +24.3% | +19.9% | +13.1% |
| FY 2021 | -3.0% | -2.2% | +5.6% | -3.4% | -6.5% | -6.4% | +14.6% | +12.0% | +6.0% | -0.2% | +4.6% | +13.4% |
| FY 2020 | -3.2% | +0.3% | -14.0% | +0.6% | +1.6% | +4.0% | -17.2% | -18.3% | +4.4% | +11.0% | +6.3% | +103.6% |
| FY 2019 | +10.6% | +15.8% | +9.0% | +19.9% | +16.1% | +16.3% | +2.0% | -39.7% | -0.9% | +16.8% | +4.5% | +134.6% |
| FY 2018 | +16.5% | +29.7% | +5.6% | +41.2% | +51.3% | +51.2% | +9.3% | -20.3% | +12.0% | +5.6% | +9.5% | -394.8% |
| FY 2017 | -3.3% | +5.5% | -7.8% | +14.4% | +18.2% | +18.1% | +16.0% | +8.4% | +12.7% | -4.9% | +5.8% | +8.7% |
| FY 2016 | +1.9% | +11.0% | +12.7% | +12.5% | +15.7% | +15.7% | -14.2% | -69.8% | +8.9% | +1.5% | +2.4% | -6.0% |
| FY 2015 | +7.7% | +7.9% | +8.3% | +6.6% | +13.2% | +13.0% | -18.7% | -29.8% | +20.1% | +1.4% | +11.5% | -9.4% |
Revenue segmentation data unavailable.
No transcripts on file.
2026-07-23EPS est $67.70